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Background: Intravenous adenosine (IVA) infusion is currently a standard method to achieve a coronary hyperemia for fractional flow reserve (FFR) 
measurement. IVA administration is cumbersome, costly, time consuming and poorly tolerated or contraindicated in certain patient subsets. We 
compared FFR response and side effect profiles of IVA and intracoronary (IC) sodium nitroprusside (NTP).
Methods: Two injections of 100 μg IC-NTP (injected over <3 seconds) were given 60 seconds apart. FFR, arterial blood pressure and heart rate 
were measured after each NTP injection. Sixty seconds after second NTP injection IVA infusion was initiated (140 micrograms/kg/min for ≥ 120 
seconds) with FFR and hemodynamic monitoring.
Results: 75 lesions were assessed in 53 patients (21 females, 32 males; mean age 61.6±13.9 years). Time to maximal decrease in FFR after NTP 
was consistently less than 10 seconds. There was no difference between FFR after the first and second NTP injection (0.835±0.109 vs. 0.836±0.107; 
t=0.08; p=0.94). Mean FFR after NTP was not different from FFR after IVA (0.836±0.107 vs. 0.856±0.106; t=1.13; p=0.26; correlation coefficient: 
r=0.908, p<0.001). The mean difference in FFR induced by NTP and IVA was similar when NTP was injected through catheters with or without side 
holes (0.016±0.048 vs. 0.014±0.036, respectively; t=0.4; p=0.86). NTP resulted in significant albeit asymptomatic systolic (by 17.5%, p<0.001), 
diastolic (by 11.5%, p<0.001) and mean (by 14%, p<0.001) blood pressures reduction. Adenosine decreased systolic, diastolic and mean blood 
pressures by 4% (p=0.33; p=0.36; p=.037, respectively). Heart rate was not significantly affected by NTP (increase by 6%, p=0.11) or adenosine 
(increase by 6%, p=0.07). During adenosine infusion fourteen patients (26%) developed shortness of breath and flushing. No patient reported 
symptoms after NTP.
Conclusions: IC- NTP at a dose of 100 micrograms achieves maximal coronary vasodilatation within 10 seconds and is as effective as intravenous 
adenosine. NTP is better tolerated by patients. Since NTP is inexpensive, readily available, well tolerated and safe it may be considered the initial 
agent of choice for FFR assessment.
